A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors

Recruiting

Phase 1

Phase 2

BMS-986490 & BevacizumabA Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors

Sponsor:

Bristol-Myers Squibb

Code:

NCT06730750

Conditions

Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMS-986490

Bevacizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-07. This information was provided to ClinicalTrials.gov by Bristol-Myers Squibb on 2025-11-14.